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ABSTRACT Salicylate is a small amphiphilic molecule which has diverse effects on membranes and membrane-mediated
processes. We have utilized micropipette aspiration of giant unilamellar vesicles to determine salicylate’s effects on lecithin
membrane elasticity, bending rigidity, and strength. Salicylate effectively reduces the apparent area compressibility modulus and
bending modulus of membranes in a dose-dependent manner at concentrations above 1 mM, but does not greatly alter the actual
elastic compressibility modulus at the maximal tested concentration of 10 mM. The effect of salicylate on membrane strength was
investigated using dynamic tension spectroscopy, which revealed that salicylate increases the frequency of spontaneous defect
formation and lowers the energy barrier for unstable hole formation. The mechanical and dynamic tension experiments are
consistent and support a picture in which salicylate disruptsmembrane stability by decreasingmembrane stiffness andmembrane
thickness. The tension-dependent partitioning of salicylate was utilized to calculate the molecular volume of salicylate in the
membrane. The free energy of transfer for salicylate insertion into the membrane and the corresponding partition coefﬁcient were
also estimated, and indicated favorable salicylate-membrane interactions. The mechanical changes induced by salicylate may
affect several biological processes, especially those associated with membrane curvature and permeability.
INTRODUCTION
Salicylate, an active metabolite of aspirin and a popular
non-steroidal anti-inﬂammatory drug (NSAID), has been
used for centuries to treat fever, pain, and arthritis (1,2). The
drug’s main therapeutic function has been attributed to its
ability to block the activity of cyclo-oxygenase (COX),
which catalyzes the production of prostaglandin from arachi-
donic acid (2,3). Prostaglandins are important signaling
molecules that regulate a number of biological processes and
are important in the mammalian immune system. However,
several of the main side-effects of salicylate and other
NSAIDs are independent of tissue prostaglandin levels
and appear not to be mediated by COX (1). These include
effects on neutrophil aggregation (4), gastric intestinal (GI)
toxicity (5,6), and reversible hearing loss (7,8). GI toxicity is
especially noteworthy, because it leads to life-threatening
ulcers. In the GI tract, gastric mucosal cells secrete phos-
pholipids which form a hydrophobic barrier that protects
the surrounding tissue from the acidic contents of the gut
(5,9,10). Lichtenberger and co-workers have accumulated
compelling evidence that the mechanism by which salicy-
late and related NSAIDs lead to ulcer formation is linked to
the ability of these molecules to chemically associate with
amphiphatic lipids and directly decrease the hydrophobicity
of the mucus gel layer (6,11–13).
Consideration of salicylate’s chemical structure suggests
that salicylate will interact with phospholipids. Salicylate
(a-hydroxybenzoic acid) is composed of a nonpolar benzene
ring and a polar domain consisting of both carboxyl-
and hydroxyl-functional groups (Fig. 1). This amphiphilic
structure points to the likelihood that salicylate will penetrate
into biomembranes and alter their physical properties. The
consequences of salicylate’s effects on membrane mechanics
have not been characterized and quantiﬁed. Membrane
mechanical properties are crucial to many cellular functions,
such as permeability, shape deformation, adhesion, commu-
nication, fusion, and endo-/exocytosis. In addition, experi-
mental evidence is accumulating that membrane elastic
properties affect the function of integral membrane proteins,
including the kinetics of ion channels (14).
Biomembranes are held together by hydrophobic forces,
which give rise to surface tension (15,16). This cohesive
force is opposed by a surface pressure, which balances with
the surface tension in the stress-free condition. The differ-
ence between the surface tension and the surface pressure
deﬁnes the membrane tension (17). Both surface tension and
surface pressure are determined by lipid packing parameters,
such as the surface area and molecular volume of the lipid
headgroup and the length of the lipid acyl chain (18,19).
When the membrane structure is perturbed by incorporation
of amphiphilic molecules, such as salicylate, the lipid pack-
ing can be changed, thereby affecting lipid-lipid interactions.
The effects of a number of amphiphilic molecules on
membrane mechanics have been investigated. For instance,
short-chain alcohols (20,21), bile acids (22), and lysolipids
(23) partition into the membrane and affect membrane elas-
ticity, bending stiffness, and lysis tension. In the case of large
surfactants, such as bile acids and lysolipids, the effects on the
elastic compressibility were attributed to tension-dependent
partitioning, i.e., the incorporation of more molecules into
the membrane as the membrane is stretched by increases in
applied pressure. In addition, small surfactants are predicted
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to change the bilayer lateral pressure proﬁle, leading to
changes in membrane mechanical moduli and thickness
(24). In this article we use micropipette aspiration of giant
unilamellar lipid vesicles (GUVs) to characterize salicy-
late’s ability to affect mechanical properties of a phospha-
tidylcholine (lecithin) membrane. We introduce a method to
correct micropipette aspiration data for tension-dependent
partitioning effects which is generally applicable to experi-
ments with soluble surfactants. A quantitative understand-
ing of the concentration dependence of salicylate’s effects
on membranes is important for ascertaining the drug’s side
effects in the physiological range.
We demonstrate that salicylate rapidly enters the mem-
brane and reduces the apparent elastic area compressibility
and bending moduli in a dose-dependent manner. Salicylate
is especially effective at decreasing bending stiffness,
although it has a smaller effect on the elastic area compres-
sibility modulus, especially after accounting for the effects of
tension-dependent partitioning. These changes are consistent
with a salicylate-induced decrease in membrane thickness.
The molecular volume of salicylate in the membrane is
estimated to be ;240 A˚3 by comparing the results of
a transfer experiment to a ‘‘sponge’’ model developed by
Evans et al. (22). The model is consistent with independent
results that salicylate molecules exist as dimers in solution
(25,26). We also estimated the free energy of transfer to be
;13.5 kJ/mol and the corresponding partition coefﬁcient to
be ;2.2 by converting our elastic compressibility moduli to
surface-tension values (21). Taken together, the results
verify that salicylate molecules prefer the membrane’s
hydrophobic environment over an aqueous one.
Finally, we explored the effects of salicylate on mem-
brane strength by applying dynamic tension spectroscopy
(DTS), a technique recently developed by Evans et al. (31).
Membrane strength is indicated by the ability of the mem-
brane to resist rupture under high values of applied tension.
Evans et al. (31) propose that rupture of membrane is a
molecular-dynamic process composed of two steps: an initial
formation of a spontaneous defect followed by subsequent
formation of an unstable hole (cavitation) that leads the
membrane to burst. In this theoretical development, the terms
‘‘defect’’ and ‘‘hole’’ refer to energetic (or thermodynamic)
states of the membrane, and do not necessarily correspond to
a particular geometry. Under this scheme, the spontaneous
defect represents a metastable state which can transition to an
unstable hole that leads to membrane failure. Both of these
processes have associated energy barriers, and the tension at
which the membrane fails depends upon the rate of pressure
loading because the rate of tension application changes the
probability of the transition from a spontaneous defect to
an unstable hole. DTS experiments reveal that salicylate
increases the frequency of spontaneous defects and signif-
icantly lowers the tension scale for cavitation. The cor-
responding edge energy of the membrane hole calculated
from the tension scale data indicates that salicylate stabilizes
membrane holes.
Our mechanical and DTS measurements point to a uniﬁed
picture in which the primary mechanical result of salicylate
partitioning at low concentrations is a reduction in the
membrane’s bending stiffness. Many undesirable side effects
of salicylate could stem from these mechanical effects on the
membrane.
MATERIALS AND METHODS
Materials
The phospholipid 1-stearoyl-2-oleoyl-phosphatidyl-choline (SOPC) was
purchased from Avanti Polar Lipids (Alabaster, AL). Lipids were dissolved
in chloroform and stored at 20C under nitrogen. Sodium salicylate and
bovine serum albumin (BSA) were purchased from Sigma-Aldrich (St.
Louis, MO). Glucose and sucrose were purchased from Fisher Scientiﬁc
(Pittsburgh, PA).
Methods
Vesicle formation
Vesicles were formed from SOPC using an electroformation procedure
(27,28). The SOPC/chloroform solution was spread on platinum electrodes
aligned parallel and ;5 mm apart from each other in a vesicle-making
chamber. The chamber was then placed in a desiccator under vacuum for at
least 2 h to ensure complete evaporation of chloroform. The dried lipid ﬁlm
was then slowly rehydrated in 200 mM sucrose solution. An alternating AC
ﬁeld with amplitude from 0.5 V to 2 V and frequency from 10 Hz to 1 Hz
was then applied to the electrodes. After ;2 h, SOPC vesicles with sizes
between 10 mm and 40 mm in diameter would form and bud off the platinum
electrodes. The vesicle solution was then collected in a glass vial and stored
at 4C under nitrogen.
We also formed SOPC GUVs using the traditional rehydration method
(29) to ensure that the lipids were not oxidized during the electroformation
process. Approximately 25 ml of 0.5 mg/ml SOPC/chloroform was spread
on the roughened surface of a Teﬂon disk and dried under vacuum in a
desiccator for at least 2 h. The Teﬂon disk with SOPC was rehydrated in
200 mM sucrose solution under N2 overnight.
Micropipette aspiration
Microaspiration measurements were conducted on the stage of a Zeiss
Axiovert 200M inverted microscope equipped with differential interference
contrast (DIC) optics. We found that superior optical quality was achieved
by using a Zeiss Plan-Neoﬂuar 403/0.85 polarized DIC objective (Carl
FIGURE 1 Chemical structures of salicylate (a) and aspirin (b) (ACD/
ChemSketch 5.0). Both compounds are benzoic acid derivatives. Aspirin is
quickly hydrolyzed to salicylate in an aqueous environment. These amphi-
philic molecules interact with membranes, potentially leading to serious side
effects.
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Zeiss, Thornwood, NY). Additional magniﬁcation was provided by a 1.6
optovar. Micropipettes used to apply pressure on lipid vesicles were
fabricated using a micropipette puller (Sutter P-97, Novato, CA) and then
broken cleanly on a custom-made microforge. A 0.02% bovine serum
albumin (BSA) solution was then used to coat the pipette. An extensive
washing of the coated pipette with both 200 mM glucose solution and
distilled water was performed in an effort to eliminate excess BSA on the
pipette (30).
The ﬁnished pipette with diameter of 8–10 mm was mounted on
a micromanipulator coupled to a water-ﬁlled reservoir and inserted into the
aspiration chamber that contains lipid vesicles suspended in isomolar
glucose/salicylate solution (200 mOsM). Pressure loading was achieved by
changing the height of a water column mounted on a motorized mechanical
slider purchased from Robocylinder (RCP-SA6I-L-600-P, Torrance, CA).
The pressure level was calibrated and periodically checked using small
vesicular debris that was found in the chamber and was small enough (;1–2
mm in diameter) to move freely through the aspirating pipette. Unilamellar
vesicles with a diameter between 18 mm and 40 mm were chosen for
experiments. When negative pressure was applied, a portion of the vesicle
would enter the pipette, creating a vesicular projection (Fig. 2 a). After each
pressure-loading step, the vesicle was given at least 10 s for salicylate
exchange to equilibrate between the vesicle and the bulk solution. This time
was chosen because a transfer experiment (fully described below) used to
characterize the timecourse of salicylate uptake indicated that it took ,10 s
for salicylate to complete its uptake into membrane (Fig. 3). After the
projection length reached steady state, aspiration images were captured
using a Zeiss Axiocam MRm camera. The vesicle and pipette dimensions
were measured and analyzed using Zeiss Axiovision 3.0 software. To obtain
accurate measurements of the projection length and the sizes of the pipette
and vesicle, comparative light intensity plots (31) of the corresponding
vesicle images were periodically used to verify the measurements obtained
from the scaling software (Fig. 2 b). All measurements were conducted at
room temperature and at the original pH of the salicylate/glucose solution.
The pH was not manipulated for the concern that additional ions could
complicate the results.
The following equations were applied to calculate membrane tension (t)
and apparent fractional area change (aapp) (32,33),
t ¼ ðPo  PpÞRp
2ð1 RP=RvÞ; (1)
aapp ¼ DA
A
¼ 2pRpDLð1 Rp=RvÞ
4pR
2
v  pR2p1 2pRpL
; (2)
where A is membrane surface area; DA is the change in membrane area
resulting from tension; Rv and Rp are radii of the aspirated vesicle and
pipette, respectively; L is the vesicle projection length; and DL is the change
in L resulting from the change in tension. Membrane tension (t) was then
plotted against the fractional area change (aapp). As shown in Fig. 4 a, a
typical plot of t versus aapp is composed of two regions. An initial expo-
nential domain corresponds to low values of applied tension (,0.5 mN/m).
In this area the work of the applied tension is predominantly used to decrease
the thermally driven out-of-plane ﬂuctuations of the membrane surface (34).
This is the reason that the geometrically measured area expansion is
designated as an apparent area change. Thermal ﬂuctuations in vesicle shape
are observed at room temperature because the bending energy is small and
comparable to the thermal energy kBT, where kB is the Boltzmann constant
and T is temperature in Kelvin (35). As the ﬂuctuations are smoothed, the t
versus aapp curve makes a transition to a region of linear elastic behavior.
The slope of the high-tension domain (.0.5 mN/m) is the apparent
compressibility modulus, Kapp (32,33). The initial low-tension region of the
plot can be used to calculate the bending modulus kc. Speciﬁcally, the slope
of the low-tension portion of a plot of ln (t) versus aapp (Fig. 4 b) is equal to
8pkc/kBT (34).
Elastic area compressibility modulus (KA)
The thermodynamic compressibility modulus characterizes the energy
associated with changing the area of the membrane. However, in the
aspiration experiments, membrane thermal ﬂuctuations are present through-
out the entire tension range, causing the measured membrane area dilation to
have contributions from smoothing thermal undulations at all tension levels
(34). To obtain the elastic compressibility modulus, denoted KA, the
fractional area increase resulting from smoothing of membrane ﬂuctuations
FIGURE 2 (a) DIC images of an aspi-
rated SOPC vesicle at a low tension of
0.01 mN/m (top) and a higher tension of
7.3 mN/m (bottom). (b) Plots of compara-
tive light intensity of the corresponding
vesicle images in a. Using the Zeiss
Axiovision 3.0 software, the light intensity
values of the images along a horizontal line
drawn across the center the pipette and
vesicle were obtained. These light intensity
data were then plotted against distance to
indicate the exact location of the edges of
the projection inside of the pipette and the
tip of the pipette, as well as the edge of the
vesicle outside of the pipette. The solid line
represents the light intensity pattern at
0.01 mN/m, and the dotted line is the pattern
at 7.3 mN/m. The small dip of the solid line
at ;74 mm indicates the edge of the
projection in the pipette. The huge variation
at;80 mm represents the tip of the pipette,
where diffraction caused large variations in
light intensity. The dip at ;110 mm is the
edge of the vesicle outside of the pipette.
The dotted line clearly shows that increasing
the tension caused an increase in the
projection length inside of the pipette.
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at each data point i was removed from the measured total area using the
model developed by Evans and Rawicz (34) and Rawicz et al. (33). The
removed fractional area increase, denoted Da(i) is equal to
DaðiÞ ¼ ðkBT=8pkcÞln½tðiÞ=tð1Þ; (3)
where t (1) is initial tension. The tension data for each vesicle was then
replotted against the elastic area dilation, denoted aA, where aA(i) ¼ aapp(i)
 Da(i). The elastic area compressibility modulus (KA) is the slope of the
t-versus-aA plot. KA will always be larger than Kapp because the total
amount of Da(i) increases with increasing tension, meaning that the slope of
the plot of t versus aA is greater than that of t versus aapp.
Transfer experiment
Soluble amphiphiles also complicate the calculation of the actual thermody-
namic compressibility modulus. The uptake of a soluble amphiphile into the
membrane is a complex kinetic process (23,36). When performing
micropipette experiments with soluble amphiphiles, it is important to know
whether the given amphiphile reaches equilibrium in the membrane and how
long the approach to equilibrium takes. Moreover, important experimental
parameters related to tension-dependent partitioning can be derived from
these experiments. Salicylate incorporation into the membrane can be
measured from the increased projection length of an aspirated vesicle exposed
to salicylate. The transfer experiments were ﬁrst conducted following
previously described methods (36,37). Brieﬂy, a chamber containing 200
mOsM glucose (the control chamber) was set side-by-side with another
chamber ﬁlled with salicylate-glucose solution at the same osmolarity (200
mOsM) on the aspiration stage. Another, much larger micropipette (transfer
pipette with diameter of at least 50mm) containing control solution (200 mM
glucose)was inserted into the chamber from the opposite side of the aspirating
pipette. An aspirated vesicle was then inserted into the transfer pipette in the
control chamber. The entire apparatus was moved to the salicylate chamber
containing glucose-salicylate solution. The timecourse of the projection
increase was recorded and converted to aapp, and the approach to equilibrium
took ,10 s. However, we were unable to record the recovery using this
standard transfer process. We attribute this to the fact that the transfer pipette
contains control solution, and the vesicle projection reaches equilibrium
during the transfer process. Thus, the transfer experiment was modiﬁed.
The modiﬁed transfer experiment utilized the same dual-chamber setup as
described above. However, the transfer pipette and thewater column linked to
the pipette were ﬁlled with a salicylate solution, instead of a control solution.
The pressure in this pipette (the salicylate pipette) was then calibrated and set
to zero in a chamber containing the same salicylate solution (the salicylate
chamber). The manipulators holding the two pipettes were prealigned so that
a rapid movement of the transfer pipette would place it exactly in front of the
vesicle pipette. During the uptake experiment, the salicylate pipette was
swiftly moved into the control chamber, the vesicle was inserted ;50-mm
deep into the salicylate pipette and the timecourse of the projection length
increase was recorded (Fig. 3). Tomonitor the projection length recovery, the
salicylate pipette was swiftly moved back into the salicylate chamber and the
recovery timecourse was recorded. The complete recovery of the vesicle
projection in 200 mM glucose (Fig. 3) indicates that the residual salicylate in
the control chamber was insigniﬁcant. This is expected due to the small
volume of solution in the pipette as compared to the large volume of solution
in the chamber. To prevent salicylate accumulation in the control chamber,
solutions were changed frequently.
Tension dependence of salicylate partitioning
In addition to determining the timecourse of salicylate uptake, the transfer
experiments can also be utilized to study the concentration- and tension-
dependence of salicylate partitioning. During an aspiration experiment, the
FIGURE 3 Kinetics of salicylate-membrane interaction. The timecourse
of salicylate uptake into a SOPC vesicle suspended in 10 mM salicylate was
obtained via the modiﬁed transfer experiment discussed in the text (for this
vesicle, the tension was ;3.5 mN/m). The open circles indicate the uptake
process. As shown, it took ;8 s for salicylate and lipids to equilibrate. The
solid circles demonstrate when salicylate was removed, the projection length
returned to its original position. The complete recovery took;20 s. Both the
original and modiﬁed transfer experiments give very similar results for the
timecourse of salicylate uptake (data of the original transfer experiments not
shown).
FIGURE 4 (a) Plot of tension (t) versus fractional area change (a) for a representative vesicle. The slope of the high tension region (.0.5 mN/m) is the
apparent area compressibility modulus (Kapp). (b) Plot of ln (t) versus a for another vesicle in which a in the low-tension region was carefully measured. The
slope of the low-tension domain of the plot was used to calculate the bending modulus (kc). Plots shown are SOPC in 200 mM glucose (s) and in 10 mM
salicylate solution at 200 mOsM (d).
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membrane is stretched and more salicylate partitions into the membrane,
making the salicylate concentration in the membrane tension-dependent. In
the extreme limit, KA could vary as a function of tension. Hence the experi-
mentally determined area dilation, aapp(i), at i
th tension level will contain
a contribution from tension-dependent partitioning of salicylate molecules,
designated apar(i). To account for this, we deﬁne a term, aAe(i), which is the
actual area increase caused by changes in lipid-lipid cohesion,
aAeðiÞ ¼ aappðiÞ  aflðiÞ  aparðiÞ; (4)
where aﬂ(i) is the area increase caused by smoothing of membrane
ﬂuctuations.
Thermodynamic theories developed for exchange of surfactants with bi-
layers can be used to obtain apar(i). At equilibrium, the chemical potential of
salicylate in the membrane is equal to that in the bulk solution (21,22),
1
ns
ln
xs
ns
 
1
m
o
s
kT
¼ m
o
m
kT
1
1
nm
ln
xm
nm
 
 t
lc
Vsal
2kT
; (5)
where mos and m
o
m are the standard chemical potentials in the solution and
inside of themembrane; xs and xm represent themole fractions of the salicylate
in solution and in vesicle membrane; Vsal is the molecular volume of the
salicylate in the membrane; t is the membrane tension; and lc is the length of
the hydrophobic core (estimated to be;3 nm) (21). The term t/lc is the lateral
pressure, whereas the terms ns and nm correspond to the number of salicylate
molecules in aggregates inside and outside of themembrane; and are included
because salicylate has been shown to form dimers in solution (25,26).
Eq. 5 indicates that the size of the salicylate molecule in the membrane
will be the operative parameter in determining apar. Vsal can be exper-
imentally determined from the modiﬁed transfer experiment described
earlier. An aspirated vesicle in the control solution was transferred into the
salicylate pipette at different constant tension levels. The projection length
change before and after the transfer at each tension was recorded and
converted to fractional area changes. Because salicylate decreases kc (see
Experimental Results, below), the uptake of salicylate will add area by
increasing membrane thermal undulations. We then removed the area in-
crease associated with membrane undulations to obtain the area increase at a
ﬁxed tension level i caused only by salicylate partitioning, designated apar(i).
Dynamic tension spectroscopy (DTS)
Traditionally, the strength of membranes has been studied by measuring
the tension at which the membrane bursts, referred to as the lysis tension
(29,38,39). However, the process of membrane lysis is complex. A recently
developed technique, dynamic tension spectroscopy (DTS), has been used to
explore the intricacies of salicylate’s effects on membrane lysis. The rupture
process of membranes consists of two steps: spontaneous defect formation
followed by cavitation (hole) formation (31). Each process is characterized
by a frequency of occurrence (n) and an associated tension scale (s).
Experimentally four parameters are obtained from DTS: the tension scales of
defect and cavitation formation, sd and sc, and the frequencies of defect and
cavitation processes, nd and nc.
We have implemented this technique, described in detail by Evans et al.
(31), in our laboratory. Brieﬂy, using the same microaspiration setup, the
motorized mechanical slider was used to apply pressure at various slider
speeds. The entire experiment from the beginning to rupture was video-
recorded using a CCD camera (Panasonic WV-BL204, Panasonic/
Matsushita, Secaucus, NJ). The video ﬁle was later converted into image
frames using X Video Converter (AoA Media, http://www.aoamedia.com)
to determine the time at which the membrane burst. The pressure loading
rate, Rs, was calculated from the slope of the plot of membrane tension
versus time (Fig. 5 a). The similar loading rate values (60.5 mN/m/s) were
grouped into bins and corresponding rupture tension measurements were
averaged. Fig. 5 b shows a plot of trupture versus log(Rs), referred to as a DTS
spectrum (31). When all data points were plotted, a very similar pattern to
the plot obtained from the averaged data was seen. For the purpose of clarity,
the averaged plot was used. Two distinct sections are present in the plot,
a low-tension domain and a high-tension domain. The nonlinear, low tension
domain represents the energy barrier for cavitation, or pore formation. The
linear, high-tension domain represents the energy barrier for forming a
spontaneous defect in the membrane. The two domains are described by the
following two equations, respectively,
s=sd  LogeðRs=nOdsdÞ; (6)
sc=s1 loge½s=scÞ5=2=ð11s=2scÞ  LogeðRs=ncscÞ:
(7)
The above equations were derived from the Markov master equations used
to describe the development of membrane rupture (31). Equation 6 applies to
spontaneous defect formation, and Eq. 7 governs cavitation formation. In
a DTS spectrum, the slope of the linear high-tension domain (loading rates of
.10 mN/m/s) is sd and the extrapolation of the slope line can be used to
calculate nd because Rs
o ¼ ndsd (31). The parameters associated with
cavitation, sc and nc, can be obtained by using Eq. 7 to ﬁt the nonlinear, low-
tension domain from the loading rates of 0.01 mN/m/s to 3 mN/m/s (31).
FIGURE 5 (a) Dependence of membrane rupture on loading rate. The results of experiments on two separate vesicles are shown. The pressure loading rate
(Rd) is the slope of the plot of membrane tension versus time. The experiment was carried out until membrane rupture. For the lower plot, vesicle rupture
occurred at a tension 3 mN/m when Rd ¼ 0.068 mN/m/s. For the upper plot, vesicle rupture occurred at 22 mN/m for Rd ¼ 7.4 mN/m/s. The results clearly
indicate that the tension needed to lyse a vesicle increases as Rd increases. (b) A dynamic tension spectrum (DTS) of membrane rupture shows two distinct
regions. The low-tension regime represents cavitation formation, whereas the high-tension regime indicates defect formation. For SOPC, sd of defect
formation is 3.2 mN/m and sc of cavitation is 197 mN/m.
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BSA affects salicylate-membrane interactions
Bovine serum albumin (BSA) is traditionally used in microaspiration
experiments to discharge the glass pipette surface (20,29,30). Initially, we
performed control experiments with SOPC in 200 mM glucose with 0.02%
BSA and found our data of Kapp to be within the acceptable range for SOPC
(;180 mN/m) and to be reproducible (mean 6 SD of ;16 mN/m for 10
vesicles). Moreover, the measured values of Kapp decreased in a dose-
dependent manner in high concentrations of salicylate (.5 mM; data not
shown). However, at low salicylate concentrations (,1 mM), the measure-
ments were irreproducible. Previous investigators have reported that
albumin binds to lipids and prevents membrane leakage (40). Shoemaker
and Vanderlick (30) reported that elastic measurements of anionic vesicles
were highly variable in the presence of BSA. Furthermore, sodium salicylate
binds to BSA in solution and prevents heat coagulation of albumin
molecules (41). Therefore, we decided to eliminate BSA in the aspiration
chamber and only coat the glass pipette tip and coverslips of the chamber
with 0.02% BSA and wash extensively with glucose solution and Millipore
water, as discussed by Shoemaker and Vanderlick (30). When conducting
studies without BSA in the system, all data became reproducible.
EXPERIMENTAL RESULTS
Apparent area compressibility measurements
We ﬁrst measured the effect of salicylate on the apparent
compressibility modulus of the membrane. A linear behavior
in the high-tension domain (.0.5 mN/m) of the plot t versus
aapp demonstrates that the membrane still behaved as linear
elastic material in the presence of salicylate. Fig. 6 shows
that salicylate decreased Kapp of SOPC in a dose-dependent
manner. The range of salicylate concentrations tested was
chosen to be 0.5–10 mM. The physiological effects of
salicylate resulting from normal aspirin consumption occur
at concentrations between 0.l and 2 mM (42). When the
blood serum level of salicylate reaches 10 mM, diverse
pathological effects occur, including myocardial necrosis
(43). The minimum amount of salicylate required to change
the apparent membrane compressibility (Kapp) was ;1 mM.
As shown in Fig. 6, 10 mM salicylate decreased Kapp from
;211 mN/m to ;138 mN/m (p , 0.05), a ;40% decrease.
Bending rigidity (kc) and elastic area
compressibility modulus (KA)
Next, we addressed the issue of whether the changes in Kapp
were due to changes in the bending stiffness (kc), the elastic
area compressibility modulus (KA), or partitioning. The
results of these experiments are shown in Figs. 7 and 8.
Salicylate decreased kc in a dose-dependent manner. The
control value of kc was measured to be ;0.9 3 10
19 J, in
agreement with earlier measurements for SOPC (21,33). We
found that 1 mM salicylate caused a ;40% decrease in kc
to ;0.6 3 1019 J. The Kapp was only reduced by ;10%
from 211 mN/m to 191 mN/m at this same concentration.
Higher concentrations of salicylate produced further decreases
in kc, though by a lesser amount than seen at 1 mM. Quali-
tative evidence for a dramatic change in the bending stiffness
comes from observations of clearly apparent thermal ﬂuctu-
ations when the vesicles were suspended in 10 mM salicylate.
Following the methods of Rawicz et al. (33), we removed
the contribution of thermal ﬂuctuations and calculated the
elastic area compressibility modulus (KA) of SOPC exposed
to salicylate. When the area increase caused by smoothing of
the undulations was removed, the KA of SOPC increased to
;246 mN/m from Kapp of ;211 mN/m. This value agrees
well with the results of Rawicz et al. (33) and Ly et al. (21).
Fig. 8 shows salicylate had less effect on KA at the higher
concentrations tested. For example,KA only decreased;20%
from ;246 mN/m to ;194 mN/m in 10 mM salicylate.
Because KA was calculated from Kapp by removing the area
increase associated with thermal ﬂuctuations, salicylate’s
small effect on KA indicates that the signiﬁcant decrease of
Kapp is mainly due to a decreased bending rigidity that causes
induced membrane ﬂuctuations.
We also repeated microaspiration experiments with GUVs
formed using the traditional rehydration method in 10 mM
FIGURE 6 The apparent area compressibility (Kapp) dose-response curve
for salicylate-SOPC interaction. Salicylate decreases Kapp of SOPC vesicles
in a dose-dependent manner. The concentrations of salicylate tested were
0 mM, 0.5 mM, 1 mM, 5 mM, and 10 mM. Error bars represent the standard
deviation of the mean.
FIGURE 7 A dose-response curve of the effect of salicylate on
membrane-bending modulus (kc) is shown. At low concentrations, salicylate
had a dramatic effect on kc.
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salicylate. The resulting mechanical parameters showed no
statistical difference from those extracted from vesicles made
via electroformation (Table 1).
Molecular volume of salicylate in the membrane
To estimate the molecular volume of salicylate, Eq. 5 can
be simpliﬁed. Assuming that the concentration of salicylate
in solution (xs) is constant because vesicle concentration in
the chamber was extremely small (in pM) and that measured
area increase reﬂects changes in the salicylate concentration
in the membrane, the equation can be derived (22) as
apar
ðxsÞnm=ns
¼ Ce tlcVsal2kTð Þ; (8)
where apar is the area dilation caused solely by partition of
salicylate molecules at each ith tension level, xs is the
salicylate concentration in solution, and C is a constant. The
term of nm/ns is an indicator of a change in the state of
molecular aggregation during partitioning. The experiments
were performed as discussed in Methods, above, to obtain
the area increase caused by tension-dependent salicylate
partitioning, designated as apar. After the membrane ﬂuc-
tuations were removed, the ln apar versus t was plotted for 1
mM and 10 mM salicylate (Fig. 9). The slopes of these plots
were extrapolated to the tension-free condition to obtain the
dependence of apar(0) on the bulk salicylate concentrations
(22). The apar(0) values at tension-free state for both 1 mM
and 10 mM salicylate were used to calculate the ratio of nm/
ns that is necessary to deduce the correlation between apar(0)
and the bulk salicylate concentration. The nm/ns value was
estimated to be ;0.5, indicating a pattern of dissociation
during insertion. The volume of a salicylate molecule was
calculated to be Vsal ;240 A˚
3 from the slope of the plots in
Fig. 9. The estimated molecular volume for methyl salicylate
is ;200 A˚3 (44), indicating that our estimated value of Vsal
is reasonable. Together with the calculated value of nm/ns,
the molecular volume data imply that salicylate molecules
exist as dimers in aqueous solution and dissociate into
monomers once in the membrane.
Calculation of the actual elastic compressibility
modulus (KAe)
The measured KA values at each bulk salicylate concentra-
tion potentially contain a contribution from the continual
partitioning of salicylate into the membrane during aspira-
tion. Although this effect is small—at the lysis tension, an
increase of ;5–10% over the initial concentration is
expected—it can become signiﬁcant for surfactants with
large packing areas. Because the chemical potential of the
solution remains constant when tension in the membrane is
changed, Eq. 5 can be written as (21,23)
1
nm
ln
xm;o
nm
 
¼ 1
nm
ln
xm;i
nm
 
 t
lc
Vsal
2kT
; (9)
FIGURE 8 (a) The effect of salicylate on KA (¤) compared with Kapp (s). The KA curve was obtained by removing the contribution from thermal
ﬂuctuations. (b) Salicylate’s effects on KA (¤) compared with its effects on the kc (n).
TABLE 1 Effect of salicylate on membrane mechanical properties of SOPC vesicles
[Sal] (mM) Kapp (mN/m) KA (mN/m) kc (10
-19 J) KAe (mN/m)
0 212 6 23 (17) 247 6 32 (7) 0.90 6 0.15 (10) 247 6 32 (7)
0.5 204 6 19 (11)
1 191 6 28* (9) 227 6 41* (9) 0.60 6 0.19* (6) 235 6 44 (9)
5 147 6 33* (23) 200 6 40* (6) 0.54 6 0.10* (7) 230 6 40 (6)
10 138 6 32* (10) 189 6 18* (7) 0.44 6 0.12* (8) 222 6 16* (7)
SOPCy (rehydration method) 10 mM Sal 128 6 27 (6) 183 6 51 (6) 0.45 6 0.17 (6) N/A
Values are shown as mean 6 SD. The numbers in parentheses represent the number of vesicles used during experiments.
*Values are statistically different from control, as determined by Student’s t-test results obtained at 95% conﬁdence.
yExperiments with SOPC GUVs synthesized via rehydration method in 10 mM salicylate. There was no statistical difference when compared to parameters
extracted from GUVs made using the electroformation method.
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where xm,o is the salicylate concentration in the membrane
at zero-tension and xm,i is the membrane salicylate con-
centration at ith tension. Eq. 9 can be simpliﬁed to express the
fractional change in the mole fraction of salicylate in the
membrane resulting from applied tension,
Dxm=xm;o ¼ exp½Vsalt=2kTlcÞnm  1; (10)
where Dxm ¼ xm,i  xm,o. Since mole fractions of salicylate
are considered to be equivalent to the area dilation, a, and
nm ¼ 1 as shown above, the above relation can be written as
DaparðiÞ ¼ ½expðVsaltðiÞ=2kTlcÞ  1aparð0Þ: (11)
Equation 11 can then be combined with Eqs. 3 and 4 to give
the total change-in-area increase that needs to be removed
to estimate the true elastic area dilation aAe(i) ¼ aapp(i) 
Da(i), where
DaðiÞ ¼ ðkBT=8pkcÞln½tðiÞ=tð1Þ1DaparðiÞ: (12)
Using Eqs. 11 and 12, we corrected the area dilation data for
all vesicles by removing apar(i) at each tension level. The
tension data were then replotted versus aAe to determine the
actual elastic compressibility modulus, designated as KAe. In
practice, this usually resulted in an approximately 10 mN/m
increase in the measured compressibility modulus for a given
vesicle. This modulus reﬂects contributions from the initial
salicylate partitioning at zero-tension. As shown in Table 1,
salicylate was found to have a much smaller effect on KAe at
all concentrations tested after the tension-dependent parti-
tioning was accounted for. The difference between KAe and
KA is small, but increases with the bulk salicylate con-
centration, as expected from Eq. 11.
The results of our micromechanical experiments are
summarized in Table 1.
Kinetics of salicylate interactions with membranes
Salicylate uptake and recovery curves were obtained using
the modiﬁed transfer experiment. The vesicle was transferred
into the salicylate pipette at a tension of ;1 mN/m and the
increase in the projection length was recorded. The fractional
area increase (a) was then plotted against time to give the
uptake timecourse (Fig. 3). The uptake curve was ﬁtted using
the general exponential growth equation, a ¼ ao 1
atð1 ek1tÞ (OriginLab, Northampton, MA), where ao is
the initial area dilation before the vesicle was exposed to
salicylate, at is the total increase in a, and k1 is the time
constant of salicylate uptake. The recovery curve was ﬁtted
with the standard exponential decay function a ¼ ao 1
Aek2t, where A is an arbitrary parameter and k2 is the time
constant of salicylate recovery. For the experiment shown in
Fig. 3, k1 was ;0.5 6 0.06 s
1 and k2 was ;0.15 6 0.08
s1. The time for equilibration of salicylate with the
membrane is much faster than that reported for the lysolipid
mono-oleoylphosphatidylcholine, where k1 ¼ 0.3 s1 (23)
and for the uptake of bile acids, which require up to;30 s to
reach equilibrium (22).
Dynamic tension spectroscopy
To test the effect of salicylate on membrane strength, we
performed dynamic tension spectroscopy (DTS). We veriﬁed
results obtained by Evans et al. (31) in control conditions and
performed experiments in 10 mM salicylate. A total of 120
vesicles were used.
As Fig. 10 shows, 10 mM salicylate clearly shifted the
DTS spectrum of an SOPC membrane. The effects were
most dramatic in the low-tension domain that represents the
cavitation process. The application of 10 mM salicylate
reduced sc to ;50 mN/m from the control value of ;129
mN/m and reduced nc to ;1 3 10
5 s1 from the control
value of ;1 3 106 s1. In the high-tension domain the
effects were not as dramatic: sdwas practically unchanged in
10 mM salicylate, and nd showed a modest increase from
FIGURE 9 Changes in the area dilation as a result of salicylate par-
titioning at various tension levels. A vesicle was transferred at constant ten-
sion levels into known concentrations of salicylate (1 mM, n, and 10 mM,
¤). Projection-length changes before and after transfer were recorded and
used to determine apar as described in the text.
FIGURE 10 Dynamic tension spectra (DTS) of SOPC in 200 mM glucose
(s) and SOPC with 10 mM salicylate (¤). The solid and dashed lines
represent the trends of the data. Salicylate does not affect sd in the high-
tension regime at this concentration. However, sc in the low-tension regime
was shifted down from ;160 mN/m (SOPC) to ;51 mN/m with 10 mM
salicylate.
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0.32 s1 to 0.98 s1. The results of the DTS experiments
are summarized in Table 2. The shift of the spectrum
demonstrates that salicylate increases the frequency of
spontaneous defects and also affects membrane strength by
lowering the energy barrier of hole formation, hence sta-
bilizing membrane holes.
The tension scale of cavitation formation is dependent
upon the edge energy of the unstable cavity, which can be
expressed as sc ¼ pe2/kBT, where e is the membrane edge
energy (31). The e-values of both pure SOPC and SOPC with
10 mM salicylate were calculated and listed in the Table 2
along with tension scale and frequency data. The results
indicate that the membrane edge energy was signiﬁcantly
lowered in the presence of salicylate.
DISCUSSION
The underlying mechanisms responsible for the diverse
biological effects of salicylate and other NSAIDs are a matter
of considerable controversy in the literature. Some maintain
that these drugs exert all their biological effects, including
therapeutic functions and side effects, as a result of direct
interactions with enzymes, such as COX (2,3). However,
others assert NSAIDs’ side effects are actually caused by
nonspeciﬁc interactions with biomembranes (1,6,11,45). It
should be noted that in Vane’s classic article, it was reported
that salicylate, which has profound anti-inﬂammatory
activity, was the least potent of the NSAIDs in inhibiting
prostaglandin biosynthesis (3), providing evidence for a non-
COX-mediated mechanism of action of salicylate and
perhaps other drugs of this class. Here, we have demon-
strated that physiological concentrations of salicylate can
have dramatic effects on the mechanical properties of an
SOPC membrane.
Salicylate decreases membrane bending rigidity
One very important point we have established is that
salicylate decreases membrane strength by affecting molec-
ular processes associated with the formation of both defects
and holes. Often in the biophysical literature the term
‘‘pores’’ is used to designate transport pathways across the
membrane without reference to a two-state model of mem-
brane rupture. Since the formation of membrane pores is
believed to govern the passive permeability of membranes
(46) and plays an important part in phospholipid trans-
location (47,48), these results imply that salicylate alters the
membrane’s hydrophobic barrier properties. In particular, we
have found that salicylate increases the frequency of
occurrence of spontaneous defects. Moreover, salicylate
signiﬁcantly lowers the tension scale of cavitation formation,
but leaves the tension scale of defect formation unaffected,
indicating that salicylate stabilizes membrane holes without
disrupting lipid cohesion. Salicylate’s small effect on the
defect process agrees with our membrane elasticity results,
which demonstrate that salicylate does not signiﬁcantly
decrease the actual elastic compressibility modulus at the
concentrations tested. The large downshift in the low-tension
domain (related to hole formation) of the DTS spectrum in
the presence of salicylate is consistent with our measure-
ments, which show that salicylate decreases membrane
bending stiffness, thereby stabilizing holes. The demon-
strated decrease in the edge energy of a hole when the
membrane was exposed to salicylate (Table 2) provides
further support for this argument. In Fig. 11, we demonstrate
that our data correlates well with the e-versus-kc data that
Evans et al. (31) presented for membranes composed of
lipids with different chain length and unsaturation levels.
Therefore, both the elasticity and dynamic tension results
coincide to show that by lowering the bending stiffness,
salicylate stabilizes membrane holes, causing a weaker and
likely a more permeable membrane.
The bending and area compressibility moduli of a thin
material are related to each other by the relationship kc ¼
KAeh
2
m=c;where hm is the thickness of the monolayer and c is
a constant (33). The result that salicylate has a large effect on
kc and a lesser effect on KAe suggests that salicylate changes
the thickness of the membrane. In Fig. 12, the plot (kc/KAe)
1/2
versus [Sal] shows that our data are consistent with a dose-
dependent thinning of the membrane. We have measured
the effect of salicylate on the height of supported mono-
layers using atomic force microscopy, and our preliminary
TABLE 2 Dynamic tension measurements
Dynamic
tension properties sd (mN/m) nd (s
1) sc (mN/m) nc(s
1) e (pJ/m)
SOPC 3.2 0.32 129 1 3 106 14.2
SOPC 1 10 mM
salicylate
3.3 0.98 51 1 3 105 7.9
FIGURE 11 The correlation between edge energy of the hole and mem-
brane-bending stiffness. The data points of e versus kc for salicylate (d) were
superimposed onto the e-versus-kc plot that Evans et al. (31) obtained for
membranes composed of lipids with different chain length and unsaturation
levels (s).
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observations indicate a noticeable thinning of the membrane
in the presence of 5 mM salicylate (data not shown).
Interestingly, membranes composed of PC lipids with acyl
chains ranging from 13 to 22 carbons and containing up to
two double bonds all have a similar KA, but kc varies widely
among these membranes; these observations are explained
by changes in membrane thickness (33). Coupled with the
correlation shown in Fig. 12, these observations suggest that
incorporation of salicylate into a PC membrane makes its
properties similar to those of a membrane composed of
shorter chain and/or polyunsaturated lipids. It is also inter-
esting to note that certain peptides, such as the antimicrobial
peptide alamethicin, can also induce pore formation by
thinning the membrane and then preferentially inserting into
the edges of the membrane pores (49–51). Moreover,
alamethicin-induced membrane thinning reaches a plateau
when the peptide/lipid ratio becomes larger than a critical
value (49), similar to the trend predicted for salicylate (Fig.
12). These considerations emphasize that the correlation
between membrane thinning and peptide-induced pore for-
mation reﬂect an underlying general biophysical mechanism.
Free energy of transfer and partition coefﬁcient
The Gibbs free energy of salicylate adsorption into the
membrane can be estimated from our experimental data
using a thermodynamic expression well developed for
monolayers (52) and recently applied to bilayers (21),
DG
0
t ¼ RT lnðdDg=dcÞc/0; (13)
where DG0t is the change in free energy associated with the
transfer of salicylate from water into the SOPC membrane.
The term (dDg/dc) represents the change in surface tension
as salicylate concentration changes. This term can be
estimated by relating the actual compressibility modulus
KAe to the surface pressure P and recalling that surface
tension is equal to surface pressure (g ¼ P) at the stress-free
state (21). Using an idealized polymer-brush model of
membrane elasticity, Rawicz et al. (33) predicted that KAe
;6P, and thus g ; KAe/6. Based on our data, DG
0
t for
salicylate partitioning into the membrane is ;13.5 6 3.9
kJ/mol. However, this value should be viewed with caution;
although we measured a change in KAe with salicylate
concentrations lower than 10 mM, a rigorous t-test did not
indicate our values were signiﬁcant at 95% level.
Because of the structural similarities between salicylate
and benzoic acid, the thermodynamics of salicylate’s inter-
action with the membrane may be comparable to that of
benzoic acid. The free energy of hydration ðDG0wÞ of benzoic
acid at 25C is;16 kJ/mol, and its free energy of solvation
in n-octanol ðDG0octÞ is ;30 kJ/mol, and so its free energy
of transfer is DG0t ¼ DG0oct  DG0w ¼ ; 15 kJ=mol (53).
This implies that hydrophobic effects play an important
role in salicylate partitioning into the membrane. The
difference may arise from the fact that salicylate, with
a pKa of ;3, would exist predominantly as an anion in
a nearly neutral solution, which can have unfavorable
electrostatic interactions with lipids. Furthermore, the
additional hydroxyl group on salicylate may lead to more
favorable interactions with the aqueous solution, thus further
decreasing DG0t :
The change in free energy of adsorption can be used to
compute the partition coefﬁcient Pmem from the standard
relationship Pmem ¼ eDG0t =RT: Our value of DG0t corre-
sponds to a log (Pmem) ;2.1. To our knowledge, we are the
ﬁrst to measure the partition coefﬁcient of salicylate into a
biological membrane. However, the partition coefﬁcient for
sodium salicylate into an octanol/water interface has been
reported to be log(Poct);1.5 (54). A recent study reports that
partition coefﬁcients for weak organic acids such as
salicylate, estimated using octanol-water interfaces (Poct),
are generally underestimates of partition coefﬁcients (Pmem)
into biological membranes (55). Notably at pH 6 where our
experiments were performed, the difference between Pmem
and Poct can be approximately an order of magnitude. Thus,
our reported partition coefﬁcient agrees with the literature
value once this correction is taken into account, which
reinforces the accuracy of our estimated value of DG0t .
From the transfer experiment, it is tempting to argue that
the time constants for salicylate uptake and recovery
represent salicylate adsorption and desorption from the
membrane. However, it is easy to illustrate that this
assumption gives incorrect results. Assuming Keq ¼ k1/k2,
the equilibrium constant, Keq, is ;3.3 6 1.8. The relation-
ship DGads ¼ RTlnKeq then gives DGads ;3 kJ/mol, and
the corresponding log (Pmem) of ;0.5. These values are
clearly too small compared to the literature value of 1.5 for
log (Pmem) (54). Thus, the experimentally observed time
constants are not indicative of adsorption and desorption
processes, but likely also reﬂect ﬂip-ﬂop and bilayer
crossing.
FIGURE 12 Predicted change in bilayer thickness, (kc/KAe)
1/2, as result of
salicylate incorporation. The estimated changes using experimentally
determined values of KAe and kc at different salicylate concentrations are
consistent with a salicylate-induced thinning of the membrane. The line is
used to indicate the trend.
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The molecular area and volume of salicylate
in an SOPC membrane
The estimated salicylate volume of ;240 A˚3 in the mem-
brane is equivalent to the physical size of one salicylate
molecule and corresponds to an estimated cross-sectional
area of;50 A˚2. Since the aromatic ring occupies most of the
physical space in a salicylate molecule, benzene can be used
for comparison in terms of packing. The cross-sectional area
of benzene varies between ;22 A˚2 and ;69 A˚2, depending
on the absorbent (56). The packing area of salicylate is
between that of bile acids (60 A˚2) (22) and lysolipids (35 A˚2)
(23). However, the interactions of salicylate with the mem-
brane are signiﬁcantly different. Whereas both bile acids and
lysolipids had large effects on membrane elasticity, salicy-
late showed a small effect on the elastic compressibility. The
difference may arise from the ﬁnding that salicylate occupies
much less volume (;240 A˚3) in the membrane than bile acids
and lysolipids (between 1000 A˚3 and 2000 A˚3). Therefore,
molecular volume becomes an important factor in ascertain-
ing the effects of small molecules on membrane elasticity.
Our results that the value of nm/ns is ;0.5 are consistent
with salicylate forming dimers in solution. The idea of
salicylate forming dimers in solution is not unusual, since the
carboxyl and hydroxyl groups covalently attached on salic-
ylate’s aromatic ring can participate in H-bonding with those
on the adjacent molecule(s) and establish a dimeric form in
solution. There is evidence that salicylate molecules exist as
dimers in solution (25), which is purported to explain salic-
ylate’s ability to induce micellar chain formation (26). In this
NMR study, salicylate molecules in one micelle were shown
to form dimers with salicylate molecules in the membranes
of neighboring micelles.
Salicylate’s membrane-mediated
biological activity
Long-term consumption of non-steroidal anti-inﬂammatory
drugs (NSAIDs), such as aspirin and salicylate, can lead to
undesirable side effects that have serious consequences. Side
effects such as gastric intestinal (GI) toxicity are related to
the ability of these drugs to interact with the membrane
(5,45,57,58). Salicylate and other NSAIDs decrease the
hydrophobicity of the membrane layer covering the gastric
mucosa, causing the membrane to become more wettable
(10,45,57,59,60). The detailed structure of the phospholipid
layer covering the GI mucosa is unknown, but the char-
acteristic structure of the GI tract is rugae and pits (61), both
of which are highly curved structures. Because salicylate is
effective at decreasing membrane bending stiffness, it is
likely to disrupt the structural integrity of the phospholipid
layer in the GI tract as well as perhaps leading to cavitation
formation.
Another non-COX-mediated effect of salicylate is on
hearing. The mechanism by which salicylate affects hearing
is due to the ability of salicylate to attenuate outer hair cell
electromotility (62,63). Some argue that salicylate affects the
function of the outer hair cell motor protein prestin by
competing with chloride ions for putative binding sites on
the molecule (64). However, the growing recognition that
protein conformational changes are associated with changes
in membrane curvature and mechanical properties (24,65)
suggests the possibility that salicylate’s ability to dramati-
cally decrease kc may be involved in its effects on
electromotility. This interpretation is consistent with the
membrane-bending model of electromotility, which propo-
ses that electrically induced changes in nanoscale membrane
curvature are involved in electromotility (66).
Finally, it is speculated that salicylate increases the water
permeability of biomembranes, including the outer hair cell
plasma membrane, by inducing the formation of membrane
pores (67). Our DTS ﬁnding supports this argument because
salicylate acts to lower the energy barrier for forming mem-
brane cavitations, thereby leading to a stabilization of the
membrane holes.
CONCLUSION
As a powerful NSAID, salicylate has been used since ancient
times to treat a series of inﬂammatory responses, such as
fever, pain, and arthritis. However, NSAIDs, including sali-
cylate, cause serious side effects. The cause of these side
effects is a subject of active debate, with some advocating
speciﬁc drug-enzyme interactions and other arguing for non-
speciﬁc drug-membrane interactions. Here, through mecha-
nical studies of micropipette aspiration and dynamic tension
spectroscopy, we have demonstrated that salicylate interacts
with lecithin membranes and changes their mechanical pro-
perties at physiological concentrations. Membranes contain-
ing salicylate have lowered bending stiffness, rupture more
easily, and are likely to be thinner and more permeable.
These mechanical changes induced by salicylate may affect
several physiological processes, especially those mediated
by membrane proteins.
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